Retatrutide

The total pooled evaluation revealed a statistically significant percent decrease in body weight of the retatrutide group when compared to the placebo group after 36 weeks of treatment, with a total MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide side effects</a> in overweight clients with or without diabetes. Early trials of retatrutide disclosed that users can lose up to a quarter of their body weight in under a year, making it nearly twice as reliable as Ozempic.